CIK 0001701108 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 66.8 M | 103.8 M | 53.5 M | |
| Net income (USD) | -89.8 M | |||
| Diluted EPS (USD/shares) | 0.15 | 0.43 | -1.23 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-10 | EFFECT | EFFECT items ,, | |
| 2026-08-28 | 8-K | 8-K items 1.01,8.01,9.01 | 2026-08-28 |
| 2026-08-28 | S-3 | S-3 | |
| 2026-08-12 | 8-K | 8-K items 2.02,9.01 | 2026-08-12 |
| 2026-08-12 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-06 | 4 | 4 | 2026-08-03 |
| 2026-08-06 | 3 | 3 | 2026-08-03 |
| 2026-07-14 | 8-K | 8-K items 1.01,2.03,7.01,8.01,9.01 | 2026-07-08 |
| 2026-06-25 | 4 | 4 | 2026-06-23 |
| 2026-06-25 | 4 | 4 | 2026-06-23 |
| 2026-06-25 | 4 | 4 | 2026-06-23 |
| 2026-06-25 | 4 | 4 | 2026-06-23 |
| 2026-06-25 | 4 | 4 | 2026-06-23 |
| 2026-06-25 | 4 | 4 | 2026-06-23 |
| 2026-06-25 | 4 | 4 | 2026-06-23 |
| 2026-06-25 | 8-K | 8-K items 5.02,5.03,5.07,9.01 | 2026-06-23 |
| 2026-06-23 | S-8 | S-8 | |
| 2026-06-22 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-06-17 |
| 2026-05-13 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-13 | 8-K | 8-K items 2.02,9.01 | 2026-05-13 |
| 2026-05-06 | 4 | 4 | 2026-05-04 |
| 2026-04-27 | ARS | ARS | 2025-12-31 |
| 2026-04-27 | DEFA14A | DEFA14A | |
| 2026-04-27 | DEF 14A | DEF 14A | 2026-06-23 |
| 2026-04-13 | PRE 14A | PRE 14A | 2026-06-23 |
Forms on file (last 1,000): 4 197, 8-K 115, 3 31, 10-Q 27, SC 13G/A 23, S-8 16, SC 13G 11, DEF 14A 9. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=SPRO (0.002 USD), /gw/filings/filings?ticker=SPRO&form=8-K, /gw/filings/facts?ticker=SPRO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange